JP2006528152A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528152A5
JP2006528152A5 JP2006520797A JP2006520797A JP2006528152A5 JP 2006528152 A5 JP2006528152 A5 JP 2006528152A5 JP 2006520797 A JP2006520797 A JP 2006520797A JP 2006520797 A JP2006520797 A JP 2006520797A JP 2006528152 A5 JP2006528152 A5 JP 2006528152A5
Authority
JP
Japan
Prior art keywords
calcitonin
agent
pharmaceutical composition
treatment
osteoarthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006520797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528152A (ja
JP4716987B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/008210 external-priority patent/WO2005014031A1/en
Publication of JP2006528152A publication Critical patent/JP2006528152A/ja
Publication of JP2006528152A5 publication Critical patent/JP2006528152A5/ja
Application granted granted Critical
Publication of JP4716987B2 publication Critical patent/JP4716987B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006520797A 2003-07-23 2004-07-22 骨関節症におけるカルシトニンの使用 Expired - Fee Related JP4716987B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48940003P 2003-07-23 2003-07-23
US60/489,400 2003-07-23
PCT/EP2004/008210 WO2005014031A1 (en) 2003-07-23 2004-07-22 Use of calcitonin in osteoarthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011035273A Division JP2011121987A (ja) 2003-07-23 2011-02-22 骨関節症におけるカルシトニンの使用

Publications (3)

Publication Number Publication Date
JP2006528152A JP2006528152A (ja) 2006-12-14
JP2006528152A5 true JP2006528152A5 (cg-RX-API-DMAC7.html) 2007-09-13
JP4716987B2 JP4716987B2 (ja) 2011-07-06

Family

ID=34135096

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006520797A Expired - Fee Related JP4716987B2 (ja) 2003-07-23 2004-07-22 骨関節症におけるカルシトニンの使用
JP2011035273A Pending JP2011121987A (ja) 2003-07-23 2011-02-22 骨関節症におけるカルシトニンの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011035273A Pending JP2011121987A (ja) 2003-07-23 2011-02-22 骨関節症におけるカルシトニンの使用

Country Status (22)

Country Link
US (3) US7749954B2 (cg-RX-API-DMAC7.html)
EP (2) EP2316473B1 (cg-RX-API-DMAC7.html)
JP (2) JP4716987B2 (cg-RX-API-DMAC7.html)
KR (1) KR101070036B1 (cg-RX-API-DMAC7.html)
CN (1) CN1856321B (cg-RX-API-DMAC7.html)
AU (2) AU2004262906B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412265A (cg-RX-API-DMAC7.html)
CA (1) CA2532565C (cg-RX-API-DMAC7.html)
ES (2) ES2436152T3 (cg-RX-API-DMAC7.html)
IL (2) IL173002A (cg-RX-API-DMAC7.html)
IS (1) IS8316A (cg-RX-API-DMAC7.html)
MA (1) MA27929A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06000807A (cg-RX-API-DMAC7.html)
NO (1) NO330867B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ544645A (cg-RX-API-DMAC7.html)
PL (2) PL2316473T3 (cg-RX-API-DMAC7.html)
PT (2) PT2316473E (cg-RX-API-DMAC7.html)
RU (1) RU2368390C2 (cg-RX-API-DMAC7.html)
TN (1) TNSN06022A1 (cg-RX-API-DMAC7.html)
TW (1) TWI343816B (cg-RX-API-DMAC7.html)
WO (1) WO2005014031A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200600373B (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005080A (es) * 2004-05-27 2005-11-30 Aspid S A De C V Una composicion moduladora de la inflamacion articular cronica a base de colagena-polivinilpirrolidona.
PE20070548A1 (es) 2005-09-19 2007-07-12 Emisphere Tech Inc Formas cristalinas de la sal de di-sodio del acido n-(5-clorosaliciloil)-8-aminocaprilico
GB0522566D0 (en) * 2005-11-04 2005-12-14 Novartis Ag Organic compounds
AU2006318815B2 (en) 2005-11-17 2010-08-19 Novartis Ag Pharmaceutical composition
EP2059260B1 (en) 2006-08-31 2013-06-19 Novartis AG Pharmaceutical compositions comprising hGH for oral delivery
WO2008109385A2 (en) * 2007-03-02 2008-09-12 Novartis Ag Oral administration of a calcitonin
WO2009019307A2 (en) * 2007-08-09 2009-02-12 Novartis Ag Oral calcitonin compositions and applications thereof
US8022048B2 (en) 2007-11-02 2011-09-20 Emisphere Technologies, Inc. Method of treating vitamin B12 deficiency
CN102123697B (zh) 2008-08-18 2015-06-10 安特拉贝欧有限公司 用于口服给予蛋白质的方法和组合物
EP2405934B1 (en) 2009-03-12 2014-03-26 Nordic Bioscience A/S Treatment of diabetes and metabolic syndrome
ES2583259T3 (es) * 2009-12-01 2016-09-20 Novo Nordisk A/S Nuevas liasas alfa-amidantes de peptidil alfa-hidroxiglicina
WO2012040364A1 (en) * 2010-09-21 2012-03-29 Unigene Laboratories Inc. Calcitonin products and therapies for treating inflammatory or degenerative diseases
CA2854175A1 (en) 2011-11-02 2013-05-10 Keybioscience Ag Peptide analogs for treating diseases and disorders
SI3095484T1 (en) 2011-11-02 2018-08-31 Keybioscience Ag Calcitonin mimetics for the treatment of diseases and disorders
AU2013234096B2 (en) * 2012-03-16 2018-08-09 Fertility Innovations Limited Processing of sperm cells
BR112016010643A2 (pt) 2013-11-14 2017-12-05 Keybioscience Ag peptídeo
CN104095828A (zh) * 2014-07-29 2014-10-15 中国药科大学 一种降钙素口服肠溶组合物及其制备方法
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
US9849125B1 (en) 2015-11-03 2017-12-26 Banner Lifie Sciences LLC Anti-overingestion dosage forms
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
US10335375B2 (en) 2017-05-30 2019-07-02 Patheon Softgels, Inc. Anti-overingestion abuse deterrent compositions
KR20190036903A (ko) 2017-09-28 2019-04-05 (주)휴럼 리트세노라이드를 유효성분으로 하는 염증과 골관절염에 대한 예방 및 치료용 약학 조성물
US11274158B2 (en) * 2018-01-30 2022-03-15 Flagship Pioneering Innovations V, Inc. Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
CN108586601B (zh) * 2018-05-14 2021-07-27 四川大学 一种骨靶向性鲑鱼降钙素及其制备方法
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
JP2023515886A (ja) 2020-03-02 2023-04-14 マジック リープ, インコーポレイテッド 没入型のオーディオプラットフォーム

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US608618A (en) 1898-08-09 Thomas millen
HU203204B (en) 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
JP3501471B2 (ja) * 1992-06-15 2004-03-02 旭化成ファーマ株式会社 カルシトニン類の安定化組成物および安定化法
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
NZ534409A (en) 1999-04-05 2006-03-31 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US6380405B1 (en) 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US20020012459A1 (en) 2000-06-22 2002-01-31 Chips Brain Co. Ltd. Method and apparatus for detecting stereo disparity in sequential parallel processing mode
EP1313699B1 (en) 2000-08-29 2010-03-10 Biocon Limited 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
US20040009980A1 (en) 2000-10-25 2004-01-15 Pradip Bhatnagar Calcilytic compounds
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
US6479692B1 (en) 2001-05-02 2002-11-12 Nobex Corporation Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
DE60233803D1 (de) 2001-08-17 2009-11-05 Novartis Ag 5-cnac zur oralen verabreichung von parathormonfragmenten

Similar Documents

Publication Publication Date Title
CA2532565A1 (en) Use of calcitonin in osteoarthritis
CN1116870C (zh) 司立吉林在制备用于预防或治疗外周神经病的药物中的应用
CN1198625C (zh) 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物
JP2021100937A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
JP2005506367A5 (cg-RX-API-DMAC7.html)
CN1440283A (zh) 有机化合物的联合形式
CN1422142A (zh) 药用组合物
CY1105648T1 (el) Filbanserin για την θεραπεια εξτραπυραμιδικων διαταραχων κινησης
WO2011028794A2 (en) Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
JP2022545156A5 (cg-RX-API-DMAC7.html)
CA2529604A1 (en) Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
JP2017514911A5 (cg-RX-API-DMAC7.html)
JP2003535895A5 (cg-RX-API-DMAC7.html)
JP2026509388A (ja) 経口投与用のglp作動薬の医薬組成物
RU2003100507A (ru) Фармацевтические композиции
CA2411882A1 (en) Solid valsartan pharmaceutical compositions
JP2026509387A (ja) 高いバイオアベイラビリティを有する経口投与用のglp作動薬の医薬組成物
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
CN1186097C (zh) 含有醛糖还原酶抑制剂和ace抑制剂的药物组合物
CA2313270A1 (en) Use of deferiprone in treating and preventing iron-induced cardiac disease
AU2003240113B2 (en) Formulation of nefopam and its use in the treatment of pain
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
CN101022808B (zh) 含有活性组分的胃滞留片剂的药物组合物
CA2620065A1 (en) Methods and formulations for modulating lyn kinase activity and treating related disorders